Cannabinoids in PLWHIV on Effective ART

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The purpose of this pilot study is to assess feasibility and to examine whether oral cannabinoids (capsules containing either Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) combined or CBD alone) are safe and well-tolerated in people living with HIV. Other aims are to determine whether oral cannabinoids may reduce HIV-associated inflammation. An exploratory objective is to determine whether oral cannabinoids may influence HIV persistence as well as the gastrointestinal microbiome.
Epistemonikos ID: 370990988c8752b25e6926ac7f4f06bc7ccc2911
First added on: Apr 23, 2019